BD's New Spanish Syringe Plant to Support European Vaccination Efforts
Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Global medical technology heavyweight Becton and Dickinson (NYSE:BDX) (BD) has announced plans to build a new high-tech manufacturing facility in the city of Zaragoza, Spain, to produce the syringes and needles needed for the massive COVID-19 vaccine rollout in Europe.
BD will invest 165 million euro (US$200 million) on the new plant, which will be located in the Aragon region of Spain and will create up to 600 jobs by 2030. Construction is expected to start on the 8,000-square-meter (86,000-square-foot) plant later this year. It will focus initially on production of prefilled syringes (PFS) for the European market, but also will add capacity for needles and syringes. The site will initially employ 150 people, but by the end of the decade is expected to employ up to 600 people across an area of 30,000 square meters (323,000 square feet). It will be designed to "high sustainability and eco-efficiency standards" and will be a fully digital site incorporating cutting edge intelligent and autonomous technologies, more commonly referred to as Industry 4.0 solutions.
This will be the company's fourth plant in Spain. BD, which has operated in Spain for more than 40 years, has production plants located in San Agustín de Guadalix, Fraga and Almaraz, which produce a total of 10 billion medical devices each year and employ 1,500 people. The Fraga plant is a key production site for the manufacture of COVID-19 vaccination injection devices. Industrial Info also is tracking projects at its existing U.S. facilities in Columbus, Nebraska, to increase the manufacture of needles and syringes.
"BD's new plant in Zaragoza will produce drug delivery devices, primarily for pharmaceutical companies that supply the European market with drugs in pre-fillable syringes such as vaccines and other biologic drugs," said Eric Borin, worldwide president of BD Pharmaceutical Systems. "This new plant will also add needed capacity to support major vaccination campaigns, such as the one currently taking place in response to the COVID-19 pandemic."
Lourdes López, general director of BD in Spain and Portugal, added: "After the December 2020 announcement of BD's intention to build a new plant in Europe, a detailed site location search process resulted in Zaragoza, Aragon, being selected because of the optimal conditions offered by the region, the synergies that could be produced with BD's Fraga facility, and the results and excellent performance of the plants that currently exist in Spain."
The new plant forms part of the US$1.2 billion investment over four years that BD announced in December 2020 to expand and upgrade manufacturing capacity and technology for pre-fillable syringes and advanced drug delivery systems (ADDS).
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, six offices in North America and 12 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. Follow IIR on: Facebook - Twitter - LinkedIn.